132 related articles for article (PubMed ID: 12413741)
1. Influences of anti-mouse interleukin-6 receptor antibody on immune responses in mice.
Mihara M; Nishimoto N; Yoshizaki K; Suzuki T
Immunol Lett; 2002 Dec; 84(3):223-9. PubMed ID: 12413741
[TBL] [Abstract][Full Text] [Related]
2. Characterization of anti-mouse interleukin-6 receptor antibody.
Okazaki M; Yamada Y; Nishimoto N; Yoshizaki K; Mihara M
Immunol Lett; 2002 Dec; 84(3):231-40. PubMed ID: 12413742
[TBL] [Abstract][Full Text] [Related]
3. Blockage of interleukin-6 receptor ameliorates joint disease in murine collagen-induced arthritis.
Takagi N; Mihara M; Moriya Y; Nishimoto N; Yoshizaki K; Kishimoto T; Takeda Y; Ohsugi Y
Arthritis Rheum; 1998 Dec; 41(12):2117-21. PubMed ID: 9870868
[TBL] [Abstract][Full Text] [Related]
4. Induction of high-dose tolerance to the rat anti-mouse IL-6 receptor antibody in NZB/NZW F1 mice.
Yoshida H; Hashizume M; Suzuki M; Mihara M
Rheumatol Int; 2011 Nov; 31(11):1445-9. PubMed ID: 20473503
[TBL] [Abstract][Full Text] [Related]
5. Anti-interleukin 6 receptor antibody inhibits murine AA-amyloidosis.
Mihara M; Shiina M; Nishimoto N; Yoshizaki K; Kishimoto T; Akamatsu K
J Rheumatol; 2004 Jun; 31(6):1132-8. PubMed ID: 15170926
[TBL] [Abstract][Full Text] [Related]
6. Effects of interleukin-6 blockade on the development of autoimmune thyroiditis in nonobese diabetic mice.
Mori K; Yoshida K; Mihara M; Ohsugi Y; Nakagawa Y; Hoshikawa S; Ozaki H; Ito S
Autoimmunity; 2009 Mar; 42(3):228-34. PubMed ID: 19301205
[TBL] [Abstract][Full Text] [Related]
7. IL-6 receptor blockage inhibits the onset of autoimmune kidney disease in NZB/W F1 mice.
Mihara M; Takagi N; Takeda Y; Ohsugi Y
Clin Exp Immunol; 1998 Jun; 112(3):397-402. PubMed ID: 9649207
[TBL] [Abstract][Full Text] [Related]
8. The paradoxical effects of lead in interferon-gamma knockout BALB/c mice.
Gao D; Kasten-Jolly J; Lawrence DA
Toxicol Sci; 2006 Feb; 89(2):444-53. PubMed ID: 16280381
[TBL] [Abstract][Full Text] [Related]
9. Treatment with anti-IL-6 receptor antibody prevented increase in serum hepcidin levels and improved anemia in mice inoculated with IL-6-producing lung carcinoma cells.
Noguchi-Sasaki M; Sasaki Y; Shimonaka Y; Mori K; Fujimoto-Ouchi K
BMC Cancer; 2016 Apr; 16():270. PubMed ID: 27068103
[TBL] [Abstract][Full Text] [Related]
10. Induction of cellular immune responses by a murine monoclonal anti-idiotypic antibody recognizing the 791Tgp72 antigen expressed on colorectal, gastric and ovarian human tumours.
Durrant LG; Doran M; Austin EB; Robins RA
Int J Cancer; 1995 Mar; 61(1):62-6. PubMed ID: 7705934
[TBL] [Abstract][Full Text] [Related]
11. The role of antigen-presenting cells in the regulation of delayed-type hypersensitivity. I. Spleen dendritic cells.
Morikawa Y; Furotani M; Kuribayashi K; Matsuura N; Kakudo K
Immunology; 1992 Sep; 77(1):81-7. PubMed ID: 1398768
[TBL] [Abstract][Full Text] [Related]
12. Anti-interleukin-6 receptor antibody (MR16-1) promotes muscle regeneration via modulation of gene expressions in infiltrated macrophages.
Fujita R; Kawano F; Ohira T; Nakai N; Shibaguchi T; Nishimoto N; Ohira Y
Biochim Biophys Acta; 2014 Oct; 1840(10):3170-80. PubMed ID: 24440156
[TBL] [Abstract][Full Text] [Related]
13. Immunosuppressive activity of an isoxazolo[5,4-e]triazepine--compound RM33. I. Effects on the humoral and cellular immune response in mice.
Ryng S; Zimecki M; Maczyński M; Chodaczek G; Kocieba M
Pharmacol Rep; 2005; 57(2):195-202. PubMed ID: 15886418
[TBL] [Abstract][Full Text] [Related]
14. The role of antigen-presenting cells in the regulation of delayed-type hypersensitivity. II. Epidermal Langerhans' cells and peritoneal exudate macrophages.
Morikawa Y; Furotani M; Matsuura N; Kakudo K
Cell Immunol; 1993 Nov; 152(1):200-10. PubMed ID: 8242760
[TBL] [Abstract][Full Text] [Related]
15. Interleukin 6 inhibits delayed-type hypersensitivity and the development of adjuvant arthritis.
Mihara M; Ikuta M; Koishihara Y; Ohsugi Y
Eur J Immunol; 1991 Oct; 21(10):2327-31. PubMed ID: 1915548
[TBL] [Abstract][Full Text] [Related]
16. Cellular and humoral adjuvant activity of lectins isolated from Korean mistletoe (Viscum album colaratum).
Yoon TJ; Yoo YC; Kang TB; Her E; Kim SH; Kim K; Azuma I; Kim JB
Int Immunopharmacol; 2001 May; 1(5):881-9. PubMed ID: 11379043
[TBL] [Abstract][Full Text] [Related]
17. IL-6 blockade preferentially inhibits Th17 differentiation in collagen-induced arthritis.
Yoshida H; Hashizume M; Mihara M
Rheumatol Int; 2011 Jan; 31(1):127-31. PubMed ID: 20658238
[TBL] [Abstract][Full Text] [Related]
18. IL-6 signal blockade ameliorates the enhanced osteoclastogenesis and the associated joint destruction in a novel FcγRIIB-deficient rheumatoid arthritis mouse model.
Ohtsuji M; Lin Q; Nishikawa K; Ohtsuji N; Okazaki H; Tsurui H; Amano H; Shirai T; Nishimoto N; Nishimura H; Hirose S
Mod Rheumatol; 2015 Mar; 25(2):270-7. PubMed ID: 25159156
[TBL] [Abstract][Full Text] [Related]
19. Blockade of interleukin-6 signaling suppresses experimental autoimmune uveoretinitis by the inhibition of inflammatory Th17 responses.
Hohki S; Ohguro N; Haruta H; Nakai K; Terabe F; Serada S; Fujimoto M; Nomura S; Kawahata H; Kishimoto T; Naka T
Exp Eye Res; 2010 Aug; 91(2):162-70. PubMed ID: 20420831
[TBL] [Abstract][Full Text] [Related]
20. CTLA4-Ig suppresses development of experimental autoimmune uveitis in the induction and effector phases: Comparison with blockade of interleukin-6.
Iwahashi C; Fujimoto M; Nomura S; Serada S; Nakai K; Ohguro N; Nishida K; Naka T
Exp Eye Res; 2015 Nov; 140():53-64. PubMed ID: 26297802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
